TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
NERV

Minerva Neurosciences Inc

Healthcare · Biotechnology

3.40$ -1.5% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow NERV
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – -1,456.1% – – – – – – –
– -49.0% -4.3% -32.9% +57.4% +824.6% +9.1% -42.2% -91.6% +263.9% -27.5% +24,120.0%
– -87.7% +62.2% +40.9% +62.6% +12.1% +5.8% -46.2% -21.3% -52.1% -32.7% +100,039.3%
– -86.4% +45.8% -221.6% – +216.8% -62.6% +157.0% -53.8% – – –
– -103.2% – +2,850.0% -99.7% +2,995.4% -1,426.4% – -1,665.7% – -106.5% –
– +14.9% +0.0% +0.0% -100.0% – +544,100.0% +0.0% +0.0% -100.0% -100.0% –
– -1,785.9% – -701.6% – -79.7% +74.1% -100.1% +0.0% – – –
– – – – – – – – – – – –
– -40.2% -33.4% -100.0% – -20.0% +2,421.5% – – – – –
– +0.0% -115.7% +214.5% -19.0% – – – – – – –
– -25.7% +99.7% -38.4% -107.1% – +2,421.5% +353.2% -100.0% – -100.0% –
– -125.5% – -182.9% – -219.1% – +797.4% -169.7% – -505.7% –
– – – – -1,479.5% – – – – – – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?